• BML-277 and the Chk2–cGAS Axis: Precision Tools for DNA Dama

  2026-05-13

  Explore the advanced role of BML-277, a potent Chk2 inhibitor, in dissecting the nuclear cGAS regulatory axis and innovating DNA damage response research. This article delivers distinct protocol insights and bridges molecular mechanisms with practical assay strategies.

• Spiroplasma eriocheiris Entry: Clathrin-Dependent and Macrop

  2026-05-13

  This study establishes that Spiroplasma eriocheiris invades Drosophila S2 cells primarily via clathrin-mediated endocytosis and macropinocytosis, not through caveola-mediated pathways. The findings clarify cellular entry mechanisms for S. eriocheiris, providing a foundation for future research on host-pathogen interactions in invertebrates.

• Nuclear cGAS Suppresses L1 Retrotransposition via Chk2-TRIM4

  2026-05-12

  This study reveals how nuclear cGAS, upon DNA damage, restricts LINE-1 (L1) retrotransposition by promoting TRIM41-mediated degradation of ORF2p, a key L1 protein. The findings elucidate a Chk2-dependent posttranslational mechanism safeguarding genome integrity, with implications for aging and cancer research.

• CBD Attenuates Orofacial Pain via Cannabinoid-Serotonin Path

  2026-05-12

  This study provides mechanistic evidence that cannabidiol (CBD) reduces both sensory pain and affective deficits in orofacial inflammatory pain models through coordinated modulation of peripheral and central cannabinoid and serotonergic pathways. The translational implications highlight CBD’s potential for multidimensional pain management.

• UBC9-Driven PINK1 SUMOylation Modulates Mitophagy in Parkins

  2026-05-11

  This study elucidates how UBC9 enhances PINK1 SUMOylation to regulate mitophagy and mitigate oxidative stress in Parkinson’s disease models. The work provides mechanistic insight into neuroprotection via post-translational modification and offers a foundation for future intervention strategies targeting mitochondrial quality control.

• Precision Mouse IgG Detection: Transforming Translational Bi

  2026-05-11

  This thought-leadership article explores the mechanistic and strategic imperatives of deploying high-sensitivity secondary antibodies—specifically the Cy3 Goat Anti-Mouse IgG (H+L) Antibody—for advancing early biomarker discovery in diabetic nephropathy. Drawing on recent quantitative proteomics breakthroughs and best-practice workflow guidance, it provides a blueprint for translational researchers seeking robust, reproducible, and clinically relevant immunodetection solutions.

• Calpeptin: Precision Calpain Inhibitor for Fibrosis Research

  2026-05-10

  Calpeptin delivers nanomolar potency and workflow versatility, enabling researchers to dissect calpain-mediated pathways in fibrosis and inflammation. This article offers advanced guidance for protocol optimization, troubleshooting, and leveraging Calpeptin’s unique strengths in translational research.

• Ouabain: Deep Mechanistic Insights for Na+/K+-ATPase Inhibit

  2026-05-09

  Explore the nuanced mechanisms and advanced research applications of Ouabain, the gold-standard selective Na+/K+-ATPase inhibitor. This article offers a deeper mechanistic and methodological perspective not found in prior guides, with practical insights for assay optimization.

• Heparin Sodium (A5066): Mechanism, Evidence & Anticoagulant

  2026-05-08

  Heparin sodium is a glycosaminoglycan anticoagulant that acts by potentiating antithrombin III to inhibit critical coagulation enzymes. This article delivers atomic, verifiable facts on its mechanism, evidence, and laboratory integration. Benchmarks and pitfalls are explicitly delineated for research use.

• Topotecan for Translational Cancer Research: Mechanism to St

  2026-05-08

  This thought-leadership article delivers a mechanistically driven, evidence-backed roadmap for translational researchers using Topotecan (SKF104864) in cancer research. Integrating insights from preclinical and clinical studies, it presents actionable strategies for experimental design, contextualizes Topotecan’s profile in pediatric solid tumors and glioma models, and highlights how APExBIO’s high-purity formulation supports reproducible, high-impact science. The article distinguishes itself by bridging detailed mechanistic understanding with strategic guidance, referencing foundational literature and recent workflow recommendations.

• EV-Transferred ACLY Drives TAM Differentiation in HCC

  2026-05-07

  This study reveals that hepatocellular carcinoma cells secrete extracellular vesicles containing ATP-citrate lyase, which induce monocyte differentiation into immunosuppressive tumor-associated macrophages (TAMs). The findings provide a mechanistic link between lipid metabolism and immune suppression in cancer, highlighting new avenues for targeted therapies.

• Lipoamino Bundle LNPs Advance mRNA Delivery to Immune Cells

  2026-05-07

  This study presents a chemically evolved class of lipoamino bundle lipid nanoparticles (LNPs) that achieve efficient mRNA transfection of dendritic cells and macrophages, with strong spleen selectivity in vivo. The findings advance the design of nonviral mRNA delivery systems, supporting more targeted and effective gene expression studies in immunologically relevant cell types.

• Bortezomib (PS-341): Advancing Proteasome Inhibition in Tran

  2026-05-06

  This thought-leadership article explores the mechanistic foundations and translational frontiers of Bortezomib (PS-341) as a reversible proteasome inhibitor, integrating recent evidence on its role in apoptosis, immune regeneration, and oncology. By dissecting both established and emerging paradigms—including thymic regeneration via proteasome inhibition—the article provides actionable guidance for translational researchers and positions APExBIO’s Bortezomib as an essential tool for innovative protocol design.

• Protein A/G Magnetic Co-IP/IP Kit: Precision in Complex Isol

  2026-05-06

  The Protein A/G Magnetic Co-IP/IP Kit delivers unmatched specificity and efficiency in isolating protein complexes and antibody purification workflows. Its recombinant magnetic beads streamline co-immunoprecipitation, supporting robust protein-protein interaction analysis and reproducible results for advanced translational research.

• One-step TUNEL FITC Apoptosis Detection Kit: Enhanced Workfl

  2026-05-05

  Accelerate apoptosis research with the One-step TUNEL FITC Apoptosis Detection Kit, offering streamlined, one-tube DNA fragmentation detection for both tissue sections and cultured cells. Discover how validated protocols, robust FITC-labeled dUTP incorporation, and actionable troubleshooting empower reproducible, high-sensitivity results.

15511 records 1/1035 page Next 12345 下5页 Last page